Statement of Principles concerning frostbite (Reasonable Hypothesis) (No. 11 of 2018)

The instrument uses a small set of technical and legal concepts to operationalise when frostbite will be treated as capable of being connected to relevant service. Key concepts, with the text source, are:

• Frostbite, defined by tissue freezing, not by related cold conditions: For this SOP frostbite “means a thermal injury involving the freezing of skin, subcutaneous tissues or deep tissues” and expressly excludes hypothermia and other cold injuries not associated with freezing of tissues (s 7(2)(a)‑(b)). The SOP notes ICD‑10‑AM codes T33, T34 or T35 are commonly used but states the statutory meaning is the s 7(2) definition (s 7(3)‑(4)).
• Death from frostbite: The instrument treats “frostbite, in relation to a person, [to] include[] death from a terminal event or condition that was contributed to by the person's frostbite” (s 7(5)). The Schedule defines “terminal event” broadly to include pneumonia, respiratory or circulatory failure, cardiac arrest, and cessation of brain function (Schedule 1).
• Relevant service: The SOP applies only where the claimant has “relevant service”, defined to include the listed categories under the VEA (operational, peacekeeping, hazardous, British nuclear test defence service) and the MRCA (warlike or non‑warlike service) (Schedule 1).
• Reasonable hypothesis as gate: The SOP is expressly framed to set the minimum factors which must exist “before it can be said that a reasonable hypothesis has been raised connecting frostbite or death from frostbite with the circumstances of a person's relevant service” (s 9). The instrument therefore identifies threshold factual/medical conditions which, if present and related to service, satisfy the RMA’s requirements for a reasonable hypothesis.
• Mandatory minimum factors: The SOP contains only two enumerated factors (s 9): (1) exposure of the affected body part to freezing temperatures within 24 hours before clinical onset, and (2) inability to obtain appropriate clinical management for frostbite. At least one of these must exist as a minimum to raise a reasonable hypothesis (s 9(1)).
• Relationship to service: Any factor relied upon must be related to the person’s relevant service (s 10(1)). The second factor (inability to obtain appropriate clinical management) is limited in application to material contribution or aggravation where the frostbite was suffered or contracted before or during, but did not arise out of, the person’s relevant service (s 10(2)).
• Cross‑reference to other SOPs: If a factor in this SOP refers to an injury or disease covered by another SOP determined under s 196B(2) VEA, then the factors in that other SOP apply in accordance with its terms (s 11). This creates potential for layered causal analysis where overlapping conditions or treatments are implicated.

Each of these concepts is defined or operationalised in the text; the SOP does not expand beyond the listed items. The ICD‑10‑AM reference is included by way of identifying common coding practice but does not change the defined meaning for the SOP (s 7(3)‑(4)). The instrument therefore ties the medico‑legal threshold mainly to a short temporal window (24 hours before clinical onset) and to access to treatment, and requires an explicit nexus to relevant service as defined in the Schedule.

This SOP is limited to persons who are making claims to which s 120A of the VEA or s 338 of the MRCA apply (s 5). That means the instrument is applied within the veterans’ entitlements and military rehabilitation/compensation claims frameworks only; the SOP does not purport to operate in other administrative or civil contexts.

Parties directly affected include:

• Claimants who are veterans, members of Peacekeeping Forces, or members of the Forces covered under the VEA or MRCA and who assert frostbite or death from frostbite in a claim under the VEA or MRCA frameworks (s 8 and s 5). The instrument’s title and text explicitly reference these cohorts (front matter, s 8).
• Decision‑makers within the agencies that administer entitlements under the VEA and MRCA. The SOP sets binding evidential/categorical expectations the RMA has determined should be used in assessing whether a reasonable hypothesis of service connection exists for frostbite or death from frostbite (s 3, s 8, s 9).
• Medical practitioners and experts preparing evidence for claims. The instrument prescribes the medical concept of frostbite for claims purposes (s 7(2)), specifies the relevant ICD‑10‑AM codes as a reference (s 7(3)‑(4)), and identifies the clinical timing and treatment access criteria that are necessary to raise a reasonable hypothesis (s 9). Medical evidence that speaks directly to those factors will be material to claim outcomes.
• Administrators dealing with overlapping conditions. Where a factor in s 9 refers to another injury or disease covered by a different SOP, the other SOP’s factors apply as in force (s 11). This influences cases with comorbid or consequential conditions.

Those who do not meet the instrument’s defined minimum factors will be directly affected because the SOP states that at least one of the factors in s 9 “must as a minimum exist” before a reasonable hypothesis is raised (s 9). The instrument therefore establishes a gate for the claims pathway for frostbite in the VEA/MRCA environment.

The SOP does not purport to create entitlements, specify benefit levels, or prescribe administrative appeals processes. It is focused on the medico‑causal question for claims. It also does not itself assign financial liability or specify which government entity pays compensation; it is applied within the existing VEA and MRCA claims frameworks (s 5, Schedule 1 definitions of VEA and MRCA).

The instrument is normative in the sense that it prescribes what must be established to raise a reasonable hypothesis of service connection for frostbite (s 9), but it does not create statutory duties or civil penalties separate from the VEA or MRCA frameworks. The practical duties and rights arising from the text are as follows:

Duties and evidentiary thresholds imposed by the SOP

• Minimum factual requirement: A claimant must have at least one of the factors in s 9 (exposure within 24 hours before clinical onset; inability to obtain appropriate clinical management) to meet the RMA’s threshold for a reasonable hypothesis connecting frostbite or death from frostbite to relevant service (s 9(1)). This is expressed as a mandatory minimum gate.
• Nexus to relevant service: Any factor relied upon must be related to the claimant’s relevant service as defined in the Schedule (s 10(1); Schedule 1 defines “relevant service” comprehensively). Thus, it is not sufficient to show a factor in isolation; the factor must be causally or materially linked to the service rendered.
• Conditional application of treatment‑access factor: The factor of inability to obtain appropriate clinical management (s 9(2)) applies only in the context of material contribution or aggravation where the frostbite was suffered or contracted before or during, but did not arise out of, relevant service (s 10(2)). This creates a particular evidentiary limitation for pre‑existing or concurrent frostbite incidents.

Rights and procedural consequences

• The instrument sets out the conditions for raising a “reasonable hypothesis”. It does not itself entitle or deny benefits; it guides the decision‑maker assessing whether a claim has met the threshold under the VEA/MRCA. The SOP therefore functions as a rights‑defining evidentiary filter within the statutory claims processes (s 5).
• Cross‑application of other SOPs: Where a factor in s 9 refers to an injury or disease covered by another SOP, the factors in that other SOP apply as in force from time to time (s 11). That means claimants and decision‑makers have the right to rely on the terms of other applicable SOPs where cross‑reference occurs.

Limitations and non‑inclusions

• The instrument does not create new statutory obligations on private parties outside the claims framework. It also does not specify administrative procedures, timelines for decisions, or appeal rights. Those matters remain governed by the VEA, MRCA and associated regulations and administrative practice (s 5).
• The SOP does not define “reasonable hypothesis” beyond setting the factors that must as a minimum exist (s 9). The instrument therefore does not itself set the legal standard of proof applicable in the broader claims scheme; it provides a RMA‑determined list of minimum medical factors for frostbite claims.

In short, the principal duty the SOP imposes is on claimants and their advisers to establish, with evidence, that at least one of the enumerated factors existed and was related to relevant service; the principal right for claimants is that when those conditions are met, a reasonable hypothesis will be regarded as raised for the purposes of claim assessment under the VEA/MRCA frameworks.

The Statement of Principles instrument is not framed as a penal instrument. The text does not create criminal offences, civil penalties, or administrative fines. Its enforcement role is limited and procedural: it supplies medical‑causal guidance that must be used in assessing whether a reasonable hypothesis linking frostbite (or death from frostbite) to relevant service has been raised for claims under the VEA or MRCA (s 3, s 5, s 9). The instrument’s enforcement consequences operate only insofar as claim decision‑makers apply the SOP within the statutory claims process.

Practical enforcement mechanics evident from the text

• Gatekeeping function: The SOP states that at least one of the factors in s 9 “must as a minimum exist before it can be said that a reasonable hypothesis has been raised” (s 9). The direct enforcement consequence is that claims lacking those minimum factors will, under this SOP, fail to satisfy the RMA’s threshold for a reasonable hypothesis. That, in turn, will affect the downstream administrative adjudication of entitlements under VEA s 120A or MRCA s 338 (s 5).
• Decision‑maker reliance: The instrument is made under the RMA’s statutory authority and therefore is intended to be used by the administrative decision‑makers who assess claims under the VEA and MRCA. The SOP’s factors will be applied as part of the assessment process; the instrument does not specify how disputes over the application are to be resolved, which remains a function of the VEA/MRCA regimes.

Absence of sanctions in the instrument

• The SOP itself does not prescribe sanctions for failure to meet its factors. The consequences of not meeting the SOP’s requirements are procedural and evidentiary,principally that the RMA’s threshold for a reasonable hypothesis has not been satisfied.
• The instrument also does not create investigatory powers or enforcement machinery. Any enforcement or review mechanisms lie in the statutory frameworks of the VEA and MRCA and their existing administrative appeal routes, not in the SOP itself (s 5).

Revocation and supersession as an enforcement mechanism

• The instrument revokes the prior frostbite SOP No. 23 of 2009 (s 4). Revocation operates to replace the prior medical‑causal framework with the current one for claims that fall within the stated commencement and application (s 2, s 5). That is a form of internal regulatory enforcement of medical standards: the RMA’s current statement is the instrument to be applied.

In sum, the instrument enforces its requirements indirectly by setting mandatory minimum medical factors for the raising of a reasonable hypothesis in claims. It does not create or impose separate statutory penalties, nor does it establish new enforcement powers beyond the RMA’s role in the claims framework.

The instrument is made under subsection 196B(2) of the Veterans' Entitlements Act 1986 (s 3) and expressly applies to claims to which s 120A of the VEA or s 338 of the MRCA apply (s 5). Its legal effect is confined to these statutory claims regimes; the SOP operates as a medical‑causal input used by decision‑makers within those legal frameworks.

Primary interactions identified in the text

• VEA and MRCA claims framework: The SOP’s stated application is to claims under the VEA (specifically s 120A) and the MRCA (s 338) (s 5). The instrument therefore interacts directly with the substantive and procedural law in those Acts, supplying medical‑causal thresholds used when determining whether a reasonable hypothesis of service connection exists for frostbite or associated death.
• RMA statutory function: The RMA determined this SOP under its statutory power in s 196B(2) of the VEA (s 3). That statutory link confirms the SOP’s role as an authoritative medical statement for the VEA/MRCA systems and binds decision‑makers that are required to apply RMA SOPs within the relevant claims processes.

Cross‑application with other Statements of Principles

• The instrument contains a built‑in mechanism to import factors from other SOPs where a factor in s 9 “refers to an injury or disease in respect of which a Statement of Principles has been determined” (s 11). If that situation arises, “the factors in that Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time” (s 11). This creates an interaction between SOPs: the current frostbite SOP will not operate in isolation if it makes reference to other injuries or diseases already covered by separate SOPs.

Relationship with ICD coding systems

• The SOP refers to ICD‑10‑AM codes T33, T34 or T35 as commonly used for frostbite, and specifies the edition and effective date (Tenth Edition, effective date 1 July 2017) (s 7(3)‑(4)). This reference recognises common clinical coding practice but the SOP clarifies that for its purposes the statutory definition in s 7(2) governs. The effect is that clinical coding may assist but does not displace the SOP’s definitional test.

Limits to interaction

• The instrument does not itself amend or replace the substantive entitlement provisions in the VEA or MRCA; it functions as a medical evidence standard to be applied under those Acts. It does not set administrative appeals, compensation levels, or entitlement criteria beyond the “reasonable hypothesis” threshold to connect frostbite or death from frostbite with relevant service (s 5).
• The SOP does not purport to operate outside the statutory claims frameworks identified in s 5. It therefore does not interact directly with other areas of law (for example tort, workers’ compensation, or criminal law) except insofar as claims might rely on medical evidence that also has relevance in other legal contexts; such cross‑jurisdictional interaction is not addressed in the instrument.

In short, the instrument interacts principally with: (a) the VEA and MRCA claims processes by supplying RMA‑determined medical factors for frostbite claims (s 5); (b) other RMA SOPs where cross‑reference occurs (s 11); and (c) clinical coding standards as an adjunct to the SOP’s definitional statements (s 7(3)‑(4)). Any further legal interaction depends on the wider statutory frameworks and administrative practice outside the SOP text.

The instrument contains limited historical and amendment information within its text. The key points recorded are:

• Instrument identification and date: Titled “Statement of Principles concerning frostbite (Reasonable Hypothesis) (No. 11 of 2018)”, the instrument is dated 22 December 2017 (front matter). The commencement date is 29 January 2018 (s 2).
• Revocation of prior SOP: The instrument expressly revokes the earlier Statement of Principles concerning frostbite No. 23 of 2009, which had been made under subsection 196B(2) of the VEA (s 4). The revocation indicates that the current instrument replaces the 2009 SOP for the purposes of claims within its application (s 5).
• Authority: The instrument was made under subsection 196B(2) of the VEA (s 3), which is the RMA’s statutory power to determine Statements of Principles. The instrument bears the RMA Common Seal and a signed direction from the Chairperson, Professor Nicholas Saunders AO (front matter), indicating formal execution through the RMA’s processes.
• No textual amendments recorded in the instrument: The text supplied does not itself include any later amending entries, schedules of amendment, or notes of modification post‑commencement. The only internal historical note is the revocation of the 2009 SOP (s 4).

Implications visible from the instrument

• The revocation indicates the RMA periodically revises SOPs to reflect updated medical‑scientific views or administrative choices. The instrument states in s 8 that the RMA “is of the view that there is sound medical‑scientific evidence” supporting the connection between frostbite and relevant service. That statement is the instrument’s internal rationale for the change, but the text does not itemise what evidence prompted the replacement of the 2009 SOP.
• The instrument also contains a cross‑reference mechanism for other SOPs (s 11). This means that future amendments to other SOPs may have consequential effects on how factors are applied in frostbite claims where cross‑references exist.

Absent material

• The instrument does not contain a schedule of amendments, transitional provisions for claims bridging the revocation date, or save‑and‑except clauses about decisions made under the prior SOP. Those matters may be addressed in the statutes or administrative practice of the Department handling claims, but they are not set out in the text provided.

For practitioners, the amendment history recorded in the instrument is limited to the replacement of the 2009 SOP by the 2018 SOP, the formal execution date and commencement date. Any further amendment or history would need to be sourced from RMA or legislative repositories beyond the instrument itself.

The Statement of Principles text provided contains no reference to litigation, court decisions, tribunal rulings, or precedents concerning its interpretation or application. The instrument itself is a statutory administrative instrument produced by the Repatriation Medical Authority; it does not include any citations to cases, nor does it summarise disputes over the SOP.

What the instrument records about disputes and procedures

• The SOP operates as a determinant of whether a “reasonable hypothesis” has been raised in claims under the VEA and MRCA (s 9, s 5). It does not, within its text, set out dispute resolution mechanisms, appeal pathways, or judicial review processes. Those procedures are addressed in the applicable statutes and administrative rules of the VEA and MRCA, not in the SOP itself.
• The instrument’s revocation of the prior SOP (s 4) is an administrative act that might give rise to contested decisions in individual claims, but the instrument does not report any litigation arising from that revocation.

Practical note for practitioners

• Because the instrument contains no litigation history, researchers and practitioners must rely on administrative records, tribunal or court databases, or agency guidance to identify whether the SOP has been the subject of judicial consideration or contested appeals. The SOP itself does not supply that material.
• Where the SOP’s factors (s 9) are determinative in an adverse claim decision, parties may challenge the decision under the review and appeal mechanisms available under the VEA or MRCA or by judicial review where appropriate. The instrument does not provide any further detail on litigation routes.

In summary, the SOP’s text contains no litigation history. The absence of recorded cases or legal commentary in the instrument means that any enquiry into how courts or tribunals have interpreted or applied this SOP must be undertaken outside the instrument itself, using external legal and administrative sources.

The instrument contains a number of discrete textual features and limitations that can catch practitioners and claimants if not attended to. These are concrete, source‑grounded pitfalls arising from the SOP’s language.

Narrow definitional scope for frostbite

• Frostbite is narrowly defined as “a thermal injury involving the freezing of skin, subcutaneous tissues or deep tissues” and expressly excludes hypothermia and other cold injuries not associated with tissue freezing (s 7(2)(a)‑(b)). A claimant whose condition is coded or described clinically as hypothermia or generalized cold injury, without clinical evidence of tissue freezing, will not meet the SOP’s definitional threshold even if the ICD code for frostbite is used elsewhere (s 7(3)). The SOP makes clear that the statutory meaning in s 7(2) governs.

ICD‑10‑AM codes are adjunctive, not definitive

• Although the SOP notes that frostbite attracts ICD‑10‑AM codes T33, T34 or T35, it also states the meaning of frostbite for the SOP is that given in s 7(2) (s 7(3)). The SOP further specifies the ICD edition and effective date (s 7(4)). That means reliance on a coding entry alone without clinical evidence of tissue freezing may be insufficient for the SOP’s purposes.

Temporal window is tight

• The principal exposure factor requires that the affected part be exposed to freezing temperatures within 24 hours before the clinical onset of frostbite (s 9(1)). Practitioners must note this short temporal window. Clinical records must link the exposure to the clinical onset within that 24‑hour period for the factor to be satisfied under the SOP.

Treatment access factor is circumscribed

• The second factor, “inability to obtain appropriate clinical management for frostbite” (s 9(2)), is not free‑standing in all contexts. Section 10(2) limits its application to cases of material contribution to, or aggravation of, frostbite where the frostbite was suffered or contracted before or during, but did not arise out of, the person’s relevant service. In other words, a failure to obtain treatment will not open the door to a reasonable hypothesis in every scenario; the timing and causal relationship to service matter.

Mandatory minimums create gating effect

• The SOP states that “At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised” (s 9). That phrasing is a strict gate. Where neither factor is present, the RMA’s SOP indicates a reasonable hypothesis cannot, under this instrument, be said to be raised. Practitioners should not assume that other forms of evidence automatically substitute for the listed factors, at least as regards the SOP’s threshold.

Death from frostbite requires contribution to a terminal event

• The instrument treats “death from frostbite” as death from a terminal event or condition that was contributed to by the person’s frostbite (s 7(5)). The definition of “terminal event” in Schedule 1 is broad and includes common causes of death such as pneumonia and cardiac arrest. Establishing that frostbite contributed to such a terminal event will require medical evidence linking the frostbite to the terminal condition, not merely evidence that both occurred.

Cross‑reference traps

• Section 11 provides that if a factor in s 9 refers to an injury or disease covered by another SOP, the factors in that other SOP apply as in force from time to time. That can generate layered evidentiary requirements and evolving standards if the other SOPs are amended. Practitioners must identify whether any factor in the frostbite SOP refers to other SOPs and if so, track changes in those SOPs.

No procedural or appeal detail provided

• The SOP is silent on procedural matters, transitional arrangements, and remedies. If a claimant’s case straddles the revocation and commencement dates, or involves decisions under the old SOP, the SOP text does not resolve transitional questions. Those practical issues lie in the wider statutory and administrative framework rather than in the SOP itself.

These gotchas are grounded in the instrument’s text. They highlight points where claim evidence, definitions, timing and cross‑references matter materially in whether a reasonable hypothesis is raised for frostbite or death from frostbite in the VEA/MRCA claims environment.

Compliance with the SOP, in the sense of meeting the RMA’s threshold that a reasonable hypothesis has been raised, requires that claimants and advisers focus on the narrow, textually specified factors and their relationship to relevant service. The SOP’s text itself provides the checklist: establish at least one of the factors in s 9 and show it is related to the person’s relevant service (s 9, s 10(1)). The following steps are derived directly from the instrument’s provisions.

1. Confirm the condition fits the SOP’s definition of frostbite

• Ensure clinical evidence demonstrates tissue freezing as the primary pathology: freezing of skin, subcutaneous tissue or deep tissue (s 7(2)(a)). If the clinical record records hypothermia or non‑freezing cold injury without tissue freezing, the SOP excludes those conditions (s 7(2)(b)).

2. If clinical coding is used, treat ICD codes as supportive, not determinative

• Note the SOP’s reference to ICD‑10‑AM codes T33, T34 and T35 and the specific edition (s 7(3)‑(4)). Use coded entries as corroborative evidence, but ensure the clinical narrative and findings demonstrate the statutory definition of frostbite.

3. Address the exposure factor precisely (s 9(1))

• To satisfy s 9(1), obtain contemporaneous or shortly after clinical records, witness accounts, service logs or other documentation showing exposure of the affected body part to freezing temperatures within the 24 hours prior to the clinical onset of frostbite. The SOP sets the 24‑hour window as the required temporal nexus.

4. If invoking inability to obtain treatment, document the limitation and satisfy s 10(2)

• If relying on s 9(2) (inability to obtain appropriate clinical management), gather records that show attempts to obtain care, reasons for failure or delay, and how this inability materially contributed to or aggravated the frostbite. Remember s 10(2) restricts this factor to cases where the frostbite was suffered or contracted before or during, but did not arise out of, the person’s relevant service.

5. Establish the relationship to relevant service (s 10(1) and Schedule 1)

• Tie the chosen factor to the claimant’s relevant service as defined in the Schedule (operational, peacekeeping, hazardous, British nuclear test defence service under the VEA, or warlike/non‑warlike under the MRCA). Documentation may include service records, deployment logs, duty rosters, orders, or other official materials that place the claimant in the relevant environment at the relevant time.

6. For claims involving death, show contribution to a terminal event (s 7(5) and Schedule 1)

• Where the claim is for death from frostbite, obtain medical evidence that frostbite contributed to the terminal event or condition (for example, pneumonia, respiratory failure, cardiac arrest, circulatory failure, or cessation of brain function as defined in Schedule 1). The SOP requires a contribution to the terminal event for death to be treated as “from frostbite” (s 7(5)).

7. Check for cross‑references to other SOPs (s 11)

• Identify whether any factor you rely on in s 9 refers to an injury or disease covered by another SOP. If so, apply the factors from that SOP “as in force from time to time” (s 11). This may create additional documentary requirements or different tests.

8. Anticipate the gatekeeping effect

• Remember the SOP’s clear wording that at least one of the factors must exist “before it can be said that a reasonable hypothesis has been raised” (s 9). If neither factor is present, the SOP indicates the RMA would not regard a reasonable hypothesis as raised within this instrument’s scope. Prepare alternative legal or factual routes only insofar as the broader VEA/MRCA frameworks might allow, noting that such alternatives are not supplied in this SOP.

9. Maintain contemporaneous clinical clarity

• Where possible, ensure that clinical onset, signs of freezing, initial management, and progression are clearly recorded in medical notes. The SOP’s 24‑hour onset requirement and its focus on clinical management make contemporaneous medical documentation especially important.

10. Be mindful of temporal and revocation dates

• The SOP commenced on 29 January 2018 and revoked the 2009 SOP (s 2, s 4). For claims spanning the revocation/commencement dates, confirm which SOP applied to the relevant decision period in administrative records, because the instrument does not itself include transitional provisions.

These compliance steps are a direct reading of the instrument. The SOP supplies a narrow, two‑factor gate: establish either the specified exposure within 24 hours of clinical onset or the specified inability to obtain appropriate clinical management in the constrained circumstances, and ensure the factor concerned is related to the person’s relevant service. Documentation that maps directly to those textual requirements is necessary to meet the RMA’s threshold as stated in the instrument.